pub 30day FRN

jbell on DSKJLSW7X2PROD with NOTICES

Federal Register / Vol. 86, No. 173 / Friday, September 10, 2021 / Notices
MSC 7808, Bethesda, MD 20892, (240) 519–
7808, [email protected].
Name of Committee: Cell Biology
Integrated Review Group; Intercellular
Interactions Study Section
Date: October 7, 2021.
Time: 11:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Thomas Y. Cho, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–402–4179, [email protected].
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group; Cell
Signaling and Molecular Endocrinology
Study Section.
Date: October 12–13, 2021.
Time: 10:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Latha Malaiyandi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 812Q,
Bethesda, MD 20892, (301) 435–1999,
[email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Innate
Immunity and Inflammation.
Date: October 13, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Liying Guo, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4198,
MSC 7812, Bethesda, MD 20892, (301) 827–
7728, [email protected].
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group; Nanotechnology Study Section.
Date: October 13–14, 2021.
Time: 9:00 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Joseph Thomas Peterson,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118,
MSC 7814, Bethesda, MD 20892, (301) 408–
9694, [email protected].
Name of Committee: Oncology 1—Basic
Translational Integrated Review Group;
Cancer Etiology Study Section.
Date: October 13–14, 2021.
Time: 10:00 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant
applications.

VerDate Sep<11>2014

18:09 Sep 09, 2021

Jkt 253001

Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sarita Kandula Sastry,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20782, (301) 402–4788, [email protected].
Name of Committee: Cell Biology
Integrated Review Group; Molecular and
Integrative Signal Transduction Study
Section.
Date: October 13, 2021.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Zubaida Saifudeen, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20817, (301) 827–3029, zubaida.saifudeen@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Research to Improve Native American
Health.
Date: October 13, 2021.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sarah Vidal, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 710Q,
Bethesda, MD 20892, (301) 402–6746,
[email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 7, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–19560 Filed 9–9–21; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Eunice Kennedy Shriver National
Institute of Child Health and Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections

Frm 00026

Fmt 4703

Sfmt 4703

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Biobehavioral and Behavioral
Sciences Study Section.
Date: November 12, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Eunice
Kennedy Shriver National Institute of Child
Health and Human Development, 6710B
Rockledge Drive, Room 2131A, Bethesda, MD
20892 (Virtual Assisted Meeting).
Contact Person: Clay Mash, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of Health,
6710B Rockledge Drive, Room 2131A,
Bethesda, MD 20892, (301) 496–6866,
[email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: September 7, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–19558 Filed 9–9–21; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Stakeholder
Measures and Advocate Forms at the
National Cancer Institute (NCI)
AGENCY:

National Institutes of Health,

HHS.

National Institutes of Health

PO 00000

50719

ACTION:

Notice.

In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.

SUMMARY:

Comments regarding this
information collection are best assured
of having their full effect if received

DATES:

E:\FR\FM\10SEN1.SGM

10SEN1

50720

Federal Register / Vol. 86, No. 173 / Friday, September 10, 2021 / Notices

within 30-days of the date of this
publication.
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.

ADDRESSES:

FOR FURTHER INFORMATION CONTACT:

Amy Williams, Director of the Office of
Advocacy Relations (OAR), NCI, NIH,
31 Center Drive, Bldg. 31, Room 10A28,
MSC 2580, Bethesda, MD 20892, call
non-toll-free number 240–781–3406, or
email your request, including your
address, to [email protected].
This
proposed information collection was
previously published in the Federal
Register on October 8, 2020, page 63565
(Vol. 85 FR 63565) and allowed 60 days
for public comment. No public
comments were received. The National
Cancer Institute (NCI), National
Institutes of Health, may not conduct or
sponsor, and the respondent is not
required to respond to, an information
collection that has been extended,
revised, or implemented on or after

SUPPLEMENTARY INFORMATION:

ensure the advocates received property
support by assessing satisfaction,
expectations, involvement, barriers, and
recruitment while working with the
NCI. OAR continues to use the database
system, which will allow this
information to be collected
electronically to match advocates easily
and appropriately to NCI initiatives and
activities as well as to assist NCI
researchers in finding advocates to
support their activities. In the previous
three years, OAR has welcomed 49
advocates into our network. Advocates
have contributed to over 30 activities,
ranging widely in scope and duration.
Several examples include speaking
engagements, Task Force appointments,
Steering Committee appointments,
webinars, Advisory Board
appointments, etc. These forms were
previously approved as, ‘‘Generic
Submission for Formative Research, Pretesting, Stakeholder Measures and
Advocate Forms at NCI’’ (OMB #: 0925–
0641, Expiration Date: 1/31/2021).
However, since OAR has not submitted
Gen ICs for the past approvals this is
being submitted as a new submission.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
16.

October 1, 1995, unless it displays a
currently valid OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: Stakeholder
Measures and Advocate Forms at the
National Cancer Institute (NCI), OMB
#0925–NEW: Expiration Date XX/XX/
XXXX, NEW, National Cancer Institute
(NCI), National Institutes of Health
(NIH).
Need and Use of Information
Collection: The Office of Advocacy
Relations (OAR) has collected data from
different stakeholder constituencies:
NIH and NCI staff, NCI-funded scientists
and staff from universities and cancer
centers, research advocates and their
advocacy organizations, and members of
scientific and professional societies and
their organizations concerned about
cancer. OAR uses the Profile
Completion Questionnaire to capture
applicant information such as basic
contact information, age, gender, race
and ethnicity, work focus, employment
status, health experiences, and research
advocacy experience. In addition, a
post-activity survey is requested to

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent

Average
time per
response
(in hours)

Total annual
burden hour

Type of respondent

Profile Completion .............................
Survey ...............................................

Individuals ........................................
Individuals ........................................

30
15

1
1

30/60
5/60

15
1

Totals .........................................

...........................................................

........................

45

........................

16

Dated: September 2, 2021.
Diane Kreinbrink,
Project Clearance Liaison, National Cancer
Institute, National Institutes of Health.
[FR Doc. 2021–19544 Filed 9–9–21; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health

jbell on DSKJLSW7X2PROD with NOTICES

Number of
respondents

Form name

National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors, NIDA.

VerDate Sep<11>2014

18:09 Sep 09, 2021

Jkt 253001

The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in sections
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
NATIONAL INSTITUTE ON DRUG
ABUSE, including consideration of
personnel qualifications and
performance, and the competence of
individual investigators, the disclosure
of which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Board of Scientific
Counselors, NIDA.
Date: October 26, 2021.
Time: 8:00 a.m. to 5:15 p.m.

PO 00000

Frm 00027

Fmt 4703

Sfmt 4703

Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: National Institute on Drug Abuse,
NIH, Biomedical Research Center, 251
Bayview Boulevard, Baltimore, MD 21224
(Virtual Meeting).
Contact Person: Deon M. Harvey, Ph.D.,
Management Analyst, Office of the Scientific
Director, National Institute on Drug Abuse,
251 Bayview Boulevard, Room 04A314,
Baltimore, MD 21224, (443) 740–2466,
[email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)

E:\FR\FM\10SEN1.SGM

10SEN1